secwatch.observer — SEC 8-K summary
======================================

Issuer:     Entrada Therapeutics, Inc. (TRDA)
CIK:        0001689375
Form:       8-K
Filed at:   2025-06-11T23:59:59+00:00
Accession:  0001104659-25-058536
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Entrada Therapeutics stockholders elect three Class I directors, ratify auditor
-------------------------------------------------------------------------------

- Elected Dipal Doshi (27,809,399 for, 429,248 withheld), Kush M. Parmar (24,883,797 for, 3,354,850 withheld), Mary Thistle (27,768,093 for, 470,554 withheld).
- Ratified Ernst & Young LLP as independent auditor for FY2025: 30,176,125 for, 74,925 against, 8,476 abstain.
- Broker non-votes on director election totaled 2,020,879 shares.
- Annual meeting held virtually on June 11, 2025; 30,259,526 shares represented (quorum).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1689375/000110465925058536/0001104659-25-058536-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1689375/000110465925058536/tm2517764d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-058536

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer